J Korean Soc Radiol.  2018 Dec;79(6):348-353. 10.3348/jksr.2018.79.6.348.

Hepatic Pseudolymphoma Mimicking a Hypervascular Tumor: A Case Report

Affiliations
  • 1Department of Radiology, Daejin Medical Center Bundang Jesaeng General Hospital, Seongnam, Korea. neverendlove@hanmail.net
  • 2Department of Pathology, Daejin Medical Center Bundang Jesaeng General Hospital, Seongnam, Korea.
  • 3Department of Internal Medicine, Daejin Medical Center Bundang Jesaeng General Hospital, Seongnam, Korea.

Abstract

Hepatic pseudolymphoma is a rare benign liver mass that is characterized by proliferation of non-neoplastic lymphocytes extranodally. To the best of our knowledge, only 46 cases have been reported in the English literature. We described the case of a 75-year-old woman with hepatic pseudolymphoma mimicking a hypervascular tumor. After the histological confirmation of the rectal neuroendocrine tumor, CT scan revealed a 1.0 cm-sized, poorly-defined and low-density nodule in the liver. On MRI, the hepatic nodule showed an arterial enhancement and a low-signal intensity on the hepatobiliary phase. On diffusion-weighted imaging, the hepatic nodule showed a high signal intensity on a high b-value. On fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT, it revealed a high standardized uptake value nodule. The US showed the hypoechoic nodule and the US-guided biopsy confirmed the hepatic pseudolymphoma.


MeSH Terms

Aged
Biopsy
Female
Humans
Liver
Lymphocytes
Magnetic Resonance Imaging
Multidetector Computed Tomography
Neuroendocrine Tumors
Positron-Emission Tomography
Pseudolymphoma*
Tomography, X-Ray Computed
Ultrasonography

Figure

  • Fig. 1 A 75-year-old woman with a hepatic pseudolymphoma. A, B. Axial contrast-enhanced CT image (A) and coronal reconstructed CT image (B) demonstrate an ill-defined low-attenuated nodule in the liver segment 8 (arrows). C. Fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT shows a high standardized uptake value (maximum standardized uptake value: 4.2) at the liver segment 8, suggesting hypermetabolic nodule (arrow). D. Intraoperative US shows a well-defined, markedly hypoechoic nodule in segment 8 (arrow). E. MRI finding of the hepatic pseudolymphoma using gadoxetic acid (Gd-EOB-DTPA-Primovist®). T2-weighted axial MR image shows a homogeneous high-signal instensity nodule in the liver segment 8 (arrowheads). On DWI, the hepatic nodule shows a high-signal intensity on a high b-value (1000 s/mm2). Gd-EOB-DTPA enhanced dynamic MR images show a homogeneous arterial enhancement and low-signal intensity on the transitional phase. The nodule shows a markedly low-signal intensity on the hepatobiliary phase. DWI = diffusion-weighted images, HBP = hepatobiliary phase, T2WI = T2-weighted images F. Histological specimen shows diffuse infiltration of lymphoid cells seen adjacent to cirrhotic liver nodule (H&E stain, × 40) and lymphocytes are mainly composed of small mature lymphocytes admixed with scattered medium and large cells. There is no cytological atypia of lymphoid cells (H&E stain, × 100). Immunostaining revealed the lymphocytes to be composed of both T cells (positive for CD3) and B cells (positive for CD79a) (H&E stain, × 200). H&E = hematoxylin and eosin stain


Reference

1.Yoshida K., Kobayashi S., Matsui O., Gabata T., Sanada J., Koda W, et al. Hepatic pseudolymphoma: imaging-pathologic correlation with special reference to hemodynamic analysis. Abdom Imaging. 2013. 38:1277–1285.
Article
2.Yang CT., Liu KL., Lin MC., Yuan RH. Pseudolymphoma of the liver: report of a case and review of the literature. Asian J Surg. 2017. 40:74–80.
Article
3.Machida T., Takahashi T., Itoh T., Hirayama M., Morita T., Horita S. Reactive lymphoid hyperplasia of the liver: a case report and review of literature. World J Gastroenterol. 2007. 13:5403–5407.
Article
4.Matsumoto N., Ogawa M., Kawabata M., Tohne R., Hiroi Y., Furuta T, et al. Pseudolymphoma of the liver: sonographic findings and review of the literature. J Clin Ultrasound. 2007. 35:284–288.
Article
5.Snover DC., Filipovich AH., Dehner LP., Krivit W. ‘Pseudolymphoma'. A case associated with primary immunodeficiency disease and polyglandular failure syndrome. Arch Pathol Lab Med. 1981. 105:46–49.
6.Okada T., Mibayashi H., Hasatani K., Hayashi Y., Tsuji S., Kaneko Y, et al. Pseudolymphoma of the liver associated with primary biliary cirrhosis: a case report and review of literature. World J Gastroenterol. 2009. 15:4587–4592.
Article
7.Taguchi K., Kuroda S., Kobayashi T., Tashiro H., Ishiyama K., Ide K, et al. Pseudolymphoma of the liver: a case report and literature review. Surg Case Rep. 2015. 1:107.
Article
8.Moon WS., Choi KH. Reactive lymphoid hyperplasia of the liver. Clin Mol Hepatol. 2013. 19:87–91.
Article
9.D'Onofrio M., Rozzanigo U., Masinielli BM., Caffarri S., Zogno A., Malagò R, et al. Hypoechoic focal liver lesions: characterization with contrast-enhanced ultrasonography. J Clin Ultrasound. 2005. 33:164–172.
10.Dorffel Y., Wermke W. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography. Ultraschall Med. 2008. 29:506–514.
Full Text Links
  • JKSR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr